Between 2001 and 2023, approximately 24% of IPOs were from biotech and pharmaceutical companies. When MarketBeat Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On ...

eXoZymes is celebrating its successful IPO and progress in biotechnology by ringing the Nasdaq closing bell on February 19, 2025. When is the Nasdaq closing bell ceremony for eXoZymes? The Nasdaq ...

Upstream Bio has become the latest ... the initial public offering (IPO) queue amid a flurry of IPO activity in the sector, with three biotechs listing on the Nasdaq last week – Bicara ...

and biofuels – today announced that CEO Michael Heltzen will be joined by eXoZymes team members to ring the Nasdaq Stock Market (“Nasdaq”) closing bell on Wednesday, February 19, 2025.

--(BUSINESS WIRE)-- Infinity Natural Resources, Inc. (“Infinity”) (NYSE: INR) announced today ... bell. “We are honored to ring the closing bell at the NYSE in celebration of our successful ...

Completed enrollment of Phase 2 clinical trial of verekitug in patients with chronic rhinosinusitis with nasal polyps; top-line data expected ...

and biofuels - today announced that CEO Michael Heltzen will be joined by eXoZymes team members to ring the Nasdaq Stock Market ("Nasdaq”) closing bell on Wednesday, February 19, 2025. This comes ...